T1	SNP 12 20	variants
T2	Entity 24 28	TSC1
T3	Entity 33 37	TSC2
T4	Association 48 59	association
E1	Association:T4 bc:T5 snp_int:T6 snp_int2:T1
T5	Cancer 65 78	breast cancer
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
T6	SNP 12 20	variants
R2	SNP_coupled_gene Arg1:T6 Arg2:T3	
T7	SNP 678 682	SNPs
T8	SNP 678 682	SNPs
T9	Entity 664 668	TSC1
T10	Entity 673 677	TSC2
T11	Association 693 705	associations
E2	Association:T11 bc:T12 snp_int:T8 snp_int2:T7
T12	Cancer 732 745	breast cancer
T13	Spec 638 645	studies
R3	Speculation_marker Arg1:E2 Arg2:T13	
R4	SNP_coupled_gene Arg1:T7 Arg2:T10	
R5	SNP_coupled_gene Arg1:T8 Arg2:T9	
T14	Entity 1141 1146	women
T15	SNP 1198 1207	rs7874234
T16	Entity 1193 1197	TSC1
T17	Entity 1209 1211	TT
R6	SNP_coupled_gene Arg1:T15 Arg2:T16	
R7	Genotype Arg1:T15 Arg2:T17	
R8	Population_assignment Arg1:T15 Arg2:T14	
T18	Association 1255 1264	diagnosis
E3	Association:T18 bc:T20 bc2:T21 snp_int:T19
T20	Cancer 1268 1294	estrogen receptor positive
A1	Cancer_Type T20 ER+
T21	Cancer 1310 1313	ER-
A2	Cancer_Type T21 ER-
T22	Cancer 1315 1332	ductal carcinomas
A3	Cancer_Type T22 ER-
R10	Equiv Arg1:T21 Arg2:T22	
T23	Entity 1315 1321	ductal
T24	Cell_types_tissues_affected 1322 1332	carcinomas
E4	Cell_types_tissues_affected:T24 Theme:T23 Agent:T15 Agent2:T19
T26	Cancer 1296 1299	ER+
A4	Cancer_Type T26 ER+
R12	Equiv Arg1:T26 Arg2:T20	
R13	Member Arg1:T2 Arg2:T15	
T19	SNP 1212 1219	variant
R9	Genotype Arg1:T19 Arg2:T17	
R14	SNP_coupled_gene Arg1:T19 Arg2:T16	
T27	Entity 1235 1264	9-year later age at diagnosis
R15	Risk_Factor Arg1:T19 Arg2:T27	
E5	Association:T18 bc:T21 snp_int:T15
R11	Population_assignment Arg1:T19 Arg2:T14	
T25	Effect_Type 1286 1294	positive
T28	Entity 1268 1285	estrogen receptor
T29	Organic_inorganic_molecules_affected 1255 1264	diagnosis
E6	Organic_inorganic_molecules_affected:T29 Agent:T15 Theme:T31
E7	Organic_inorganic_molecules_affected:T29 Agent:T19 Theme:T28
R16	Effect_type_marker Arg1:E7 Arg2:T25	
A5	Effect_Type E7 Increase
T30	Neg 1312 1313	-
R17	Negation_marker Arg1:E6 Arg2:T30	
T31	Entity 1310 1312	ER
T32	Entity 1450 1454	TSC1
T33	SNP 1455 1464	rs7874234
R18	SNP_coupled_gene Arg1:T33 Arg2:T32	
T34	Spec 1468 1480	hypothesized
T35	Association 1487 1497	functional
E8	Association:T35 snp_int:T33 bc:T36
R19	Speculation_marker Arg1:E8 Arg2:T34	
T36	Cancer 1501 1518	ER+ breast cancer
A6	Cancer_Type T36 ER+
T37	Entity 1531 1539	T allele
R20	SNP_allele Arg1:T33 Arg2:T37	
T38	Neg 1545 1548	not
T39	Entity 1553 1561	C allele
R21	Negation_marker Arg1:T39 Arg2:T38	
R22	SNP_allele Arg1:T33 Arg2:T39	
T40	Spec 1563 1566	may
T41	Entity 1577 1602	estrogen receptor element
T42	Entity 1604 1607	ERE
R23	Equiv Arg1:T42 Arg2:T41	
T43	Effect_Type 1628 1637	increased
T44	Gene_Regulation 1643 1656	transcription
E9	Gene_Regulation:T44 Theme:T45 Agent:T33
A7	Effect_Type E9 Increase
R24	Effect_type_marker Arg1:E9 Arg2:T43	
T45	Entity 1638 1642	TSC1
T46	Organic_inorganic_molecules_affected 1672 1682	inhibition
E10	Organic_inorganic_molecules_affected:T46 Theme:T47 Agent:T33
T47	Entity 1686 1690	mTOR
R25	Speculation_marker Arg1:E9 Arg2:T40	
R26	Speculation_marker Arg1:E10 Arg2:T40	
T48	Organic_inorganic_molecules_affected 1567 1573	create
E11	Organic_inorganic_molecules_affected:T48 Theme:T41 Agent:T33
R27	Speculation_marker Arg1:E11 Arg2:T40	
T49	Effect_Type 1672 1682	inhibition
R28	Effect_type_marker Arg1:E10 Arg2:T49	
A8	Effect_Type E10 Decrease
R29	Population_assignment Arg1:T33 Arg2:T14	
R30	Member Arg1:T1 Arg2:T15	
T50	SNP 1350 1359	other SNP
T51	Association 1376 1387	association
E12	Association:T51 snp_int:T50 bc:T53
T52	Entity 1393 1409	age at diagnosis
R31	Risk_Factor Arg1:T50 Arg2:T52	
T53	Cancer 1425 1438	breast cancer
T54	Neg 1347 1349	No
R32	Negation_marker Arg1:E12 Arg2:T54	
R33	Member Arg1:T6 Arg2:T50	
R34	Member Arg1:T1 Arg2:T50	
